ODI Pharma AB (publ) (NGM:ODI)
2.000
+0.220 (12.36%)
At close: Jun 13, 2025
ODI Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
Cash & Equivalents | 2 | 2.64 | 6.49 | 7.36 | 14.62 | 20.51 | Upgrade
|
Cash & Short-Term Investments | 2 | 2.64 | 6.49 | 7.36 | 14.62 | 20.51 | Upgrade
|
Cash Growth | -66.20% | -59.28% | -11.76% | -49.69% | -28.71% | 364.06% | Upgrade
|
Accounts Receivable | 3.33 | 8.07 | 0.13 | 0.11 | - | - | Upgrade
|
Other Receivables | 1.48 | 0.91 | 0.68 | 0.99 | 0.93 | 0.18 | Upgrade
|
Receivables | 4.8 | 8.98 | 0.81 | 1.09 | 0.93 | 0.18 | Upgrade
|
Inventory | - | - | 0.81 | 1.43 | 1.05 | - | Upgrade
|
Prepaid Expenses | 0.56 | 0.59 | 0.06 | - | - | 0.15 | Upgrade
|
Other Current Assets | - | - | 0 | 0.6 | 0.26 | - | Upgrade
|
Total Current Assets | 7.37 | 12.22 | 8.18 | 10.48 | 16.87 | 20.84 | Upgrade
|
Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
Other Long-Term Assets | - | 0 | - | - | - | - | Upgrade
|
Total Assets | 7.38 | 12.23 | 8.19 | 10.5 | 16.88 | 20.86 | Upgrade
|
Accounts Payable | 2.93 | 5 | 0.71 | 0.67 | 0.15 | 0.3 | Upgrade
|
Accrued Expenses | 0.47 | 1.16 | 0.35 | - | - | - | Upgrade
|
Current Income Taxes Payable | - | 0.09 | 0 | - | - | 0.3 | Upgrade
|
Current Unearned Revenue | - | - | - | 0.55 | 0.4 | 0.18 | Upgrade
|
Other Current Liabilities | 3.13 | 3.98 | 4.54 | 0.01 | 0.04 | - | Upgrade
|
Total Current Liabilities | 6.53 | 10.23 | 5.61 | 1.24 | 0.58 | 0.79 | Upgrade
|
Total Liabilities | 6.53 | 10.23 | 5.61 | 1.24 | 0.58 | 0.79 | Upgrade
|
Common Stock | 0.64 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | Upgrade
|
Additional Paid-In Capital | 24.05 | 21.84 | 21.84 | 21.84 | 21.84 | 21.58 | Upgrade
|
Comprehensive Income & Other | -23.84 | -20.45 | -19.88 | -13.19 | -6.15 | -2.12 | Upgrade
|
Shareholders' Equity | 0.84 | 2 | 2.57 | 9.26 | 16.3 | 20.08 | Upgrade
|
Total Liabilities & Equity | 7.38 | 12.23 | 8.19 | 10.5 | 16.88 | 20.86 | Upgrade
|
Net Cash (Debt) | 2 | 2.64 | 6.49 | 7.36 | 14.62 | 20.51 | Upgrade
|
Net Cash Growth | -66.20% | -59.28% | -11.76% | -49.69% | -28.71% | 364.06% | Upgrade
|
Net Cash Per Share | 0.13 | 0.17 | 0.42 | 0.49 | 0.95 | 1.49 | Upgrade
|
Filing Date Shares Outstanding | 15.92 | 15.22 | 15.22 | 15.22 | 15.22 | 15.22 | Upgrade
|
Total Common Shares Outstanding | 15.92 | 15.22 | 15.22 | 15.22 | 15.22 | 15.22 | Upgrade
|
Working Capital | 0.84 | 1.99 | 2.56 | 9.25 | 16.29 | 20.06 | Upgrade
|
Book Value Per Share | 0.05 | 0.13 | 0.17 | 0.61 | 1.07 | 1.32 | Upgrade
|
Tangible Book Value | 0.84 | 2 | 2.57 | 9.26 | 16.3 | 20.08 | Upgrade
|
Tangible Book Value Per Share | 0.05 | 0.13 | 0.17 | 0.61 | 1.07 | 1.32 | Upgrade
|
Machinery | - | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.